Analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the stock.
Retractable Technologies Stock Performance
RVP opened at $0.62 on Wednesday. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.34. The stock has a market cap of $18.41 million, a PE ratio of -1.14 and a beta of 2.06. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock’s 50 day simple moving average is $0.71 and its 200-day simple moving average is $0.93.
Insider Buying and Selling at Retractable Technologies
In other Retractable Technologies news, CEO Thomas J. Shaw acquired 71,422 shares of Retractable Technologies stock in a transaction on Friday, September 20th. The shares were bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now owns 14,743,907 shares in the company, valued at $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last ninety days, insiders have purchased 179,515 shares of company stock valued at $143,037. 55.00% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Retractable Technologies
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Further Reading
- Five stocks we like better than Retractable Technologies
- EV Stocks and How to Profit from Them
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Pros And Cons Of Monthly Dividend Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is MarketRankā¢? How to Use it
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.